wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34389202-401C3343-254D-47CF-8C39-B0B7E819A215
Q34389202-401C3343-254D-47CF-8C39-B0B7E819A215
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34389202-401C3343-254D-47CF-8C39-B0B7E819A215
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.
P2860
Q34389202-401C3343-254D-47CF-8C39-B0B7E819A215
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34389202-401C3343-254D-47CF-8C39-B0B7E819A215
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
174b3663911d6e33b5a258cdf155be059697bec4
P2860
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group